<!DOCTYPE html SYSTEM "about:legacy-compat">
<html class="no-js">
  <head>
    <meta charset="utf-8"/>
    <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"/>
    <title>DC Code - Chapter 8G. Prescription Drug Monitoring.</title>
    <meta property="st:title" content="Chapter 8G. Prescription Drug Monitoring."/>
    <meta name="description" content="A simple, free browser for the Washington, DC Code"/>
    <meta name="viewport" content="width=device-width"/>
    <link href="https://fonts.googleapis.com/css?family=Open+Sans:400italic,700italic,400,700" rel="stylesheet" type="text/css"/>
    <link rel="stylesheet" type="text/css" href="/css/main.css" media="screen"/>
    <link rel="stylesheet" type="text/css" href="/css/print.css" media="print"/>
    <script type="text/javascript">
            var _paq = _paq || [];
            _paq.push(['trackPageView']);
            _paq.push(['enableLinkTracking']);
            (function() {
              var u="//analytics.code.dccouncil.us/";
              _paq.push(['setTrackerUrl', u+'piwik.php']);
              _paq.push(['setSiteId', 1]);
              var d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0];
              g.type='text/javascript'; g.async=true; g.defer=true; g.src=u+'piwik.js'; s.parentNode.insertBefore(g,s);
            })();

          window.searchHost = 'https://search.code.dccouncil.us';
          window.queryUrl = '/v1/search';
          </script>
    <noscript>
      <p>
        <img src="//analytics.code.dccouncil.us/piwik.php?idsite=1" style="border:0;" alt=""/>
      </p>
    </noscript>
  </head>
  <body>
    <header>
      <section class="container">
        <div class="right no-print search" id="search"> </div>
        <h1 id="sitename">
          <a href="/dc/council/code/">Code of the District of Columbia</a>
        </h1>
      </section>
    </header>
    <main class="main container">
      <div class="clearfix" style="width: 100%;">
        <aside id="sidebar" class="col4 quiet">
          <h2>You Are Here</h2>
          <ul class="ancestors">
            <li data-search-path="library" data-search-heading="All Documents">↪ <a href="/">D.C. Law Library</a></li>
            <li data-search-path="library|D.C. Code" data-search-heading="D.C. Code">↪ <a href="/dc/council/code/">Code of the District of Columbia</a></li>
            <li data-search-path="library|D.C. Code|48" data-search-heading="Title 48">↪ <a href="/dc/council/code/titles/48/">Title 48. Foods and Drugs.</a></li>
            <li data-search-path="library|D.C. Code|48|8G" data-search-heading="Chapter 8G">↪ Chapter 8G. Prescription Drug Monitoring.</li>
          </ul>
          <h2>Previous</h2>
          <p>
            <a href="/dc/council/code/titles/48/chapters/8F/">Chapter 8F. Safe Disposal of Unused Pharmaceuticals.</a>
          </p>
          <h2>Next</h2>
          <p>
            <a href="/dc/council/code/titles/48/chapters/8H/">Chapter 8H. Specialty Drug Copayment Limitation.</a>
          </p>
          <h2>Publication Information</h2>
          <h3>Current through July 11, 2017</h3>
          <dl id="recency">
            <dt>Last codified D.C. Law:</dt>
            <dd>
          Law 22-5 effective July 11, 2017</dd>
            <dt>Last codified Emergency Law:</dt>
            <dd>
          Act 21-354 effective Mar. 23, 2016</dd>
            <dt>Last codified Federal Law:</dt>
            <dd>
          Public Law  approved May 5, 2017</dd>
          </dl>
          <section class="cta">
            <p>
              <a href="mailto:code@dccouncil.us?subject=[ERROR]+/dc/council/code/titles/48/chapters/8G/">Report Error</a>
            </p>
            <p>
              <a href="mailto:code@dccouncil.us?subject=[FEEDBACK]+/dc/council/code/titles/48/chapters/8G/">Website Feedback</a>
            </p>
            <p>We cannot respond to questions regarding the law.</p>
          </section>
        </aside>
        <section class="col8 body">
          <h1>Chapter 8G. Prescription Drug Monitoring.</h1>
          <section class="line-group toc child-link">
            <a href="/dc/council/code/sections/48-853.01.html">§ 48–853.01. Definitions.</a>
            <a href="/dc/council/code/sections/48-853.02.html">§ 48–853.02. Program establishment; Director’s authority.</a>
            <a href="/dc/council/code/sections/48-853.03.html">§ 48–853.03. Reporting requirements; exceptions.</a>
            <a href="/dc/council/code/sections/48-853.04.html">§ 48–853.04. Authority to access database.</a>
            <a href="/dc/council/code/sections/48-853.05.html">§ 48–853.05. Confidentiality of data; disclosure of information; discretionary authority of the Director.</a>
            <a href="/dc/council/code/sections/48-853.06.html">§ 48–853.06. Interoperability; information exchange with other prescription drug monitoring programs.</a>
            <a href="/dc/council/code/sections/48-853.07.html">§ 48–853.07. Criteria for indicators of misuse; Director’s authority to disclose information; intervention.</a>
            <a href="/dc/council/code/sections/48-853.08.html">§ 48–853.08. Immunity from liability.</a>
            <a href="/dc/council/code/sections/48-853.09.html">§ 48–853.09. Unlawful disclosure of information and acts; disciplinary action authorized; penalties.</a>
            <a href="/dc/council/code/sections/48-853.10.html">§ 48–853.10. Rules.</a>
          </section>
          <section class="content">
            <hr/>
            <h1>§ 48–853.01. Definitions.</h1>
            <section>
              <section class="line-group primary-content">
                <p>For the purposes of this chapter, the term:</p>
                <p class="text-indent-1"><span class="level-num" id="(1)">(1)</span> “Administer” shall have the same meaning as provided in § <a class="internal-link" href="/dc/council/code/sections/48-901.02.html">48-901.02</a>(1).</p>
                <p class="text-indent-1"><span class="level-num" id="(2)">(2)</span> “Controlled substance” shall have the same meaning as provided in § <a class="internal-link" href="/dc/council/code/sections/48-901.02.html">48-901.02</a>(4).</p>
                <p class="text-indent-1"><span class="level-num" id="(3)">(3)</span> “Controlled Substances Act” means Unit A of Chapter 9 of this title [§ <a class="internal-link" href="/dc/council/code/sections/48-901.01.html">48-901.01</a> et seq.].</p>
                <p class="text-indent-1"><span class="level-num" id="(4)">(4)</span> “Covered substance” means all controlled substances included in the schedules set forth in §§ <a class="internal-link" href="/dc/council/code/sections/48-902.06.html">48-902.06</a>, <a class="internal-link" href="/dc/council/code/sections/48-902.08.html">48-902.08</a>, <a class="internal-link" href="/dc/council/code/sections/48-902.10.html">48-902.10</a>, and <a class="internal-link" href="/dc/council/code/sections/48-902.12.html">48-902.12</a>, in schedules II through V of section 202(c) of Title II of the Comprehensive Drug Abuse Prevention and Control Act of 1970, approved October 27, 1970 (84 Stat. 1247; 21 U.S.C. § 812), and any other drug, as specified by rulemaking, that is required to be reported to the Prescription Drug Monitoring Program pursuant to this chapter.</p>
                <p class="text-indent-1"><span class="level-num" id="(5)">(5)</span> “Department” means the Department of Health.</p>
                <p class="text-indent-1"><span class="level-num" id="(6)">(6)</span> “Director” means the Director of the Department of Health.</p>
                <p class="text-indent-1"><span class="level-num" id="(7)">(7)</span> “Dispense” shall have the same meaning as provided in § <a class="internal-link" href="/dc/council/code/sections/48-901.02.html">48-901.02</a>(7).</p>
                <p class="text-indent-1"><span class="level-num" id="(8)">(8)</span> “Dispenser” means a practitioner who dispenses a covered substance to the ultimate user, or his or her agent, but shall not include:</p>
                <p class="text-indent-2"><span class="level-num" id="(8)(A)">(A)</span> A licensed hospital or institutional facility pharmacy that distributes covered substances for the purpose of inpatient hospital care or the dispensing of prescriptions for controlled substances at the time of discharge from such a facility;</p>
                <p class="text-indent-2"><span class="level-num" id="(8)(B)">(B)</span> A practitioner or other authorized person who administers a covered substance;</p>
                <p class="text-indent-2"><span class="level-num" id="(8)(C)">(C)</span> A wholesale distributor of a covered substance; or</p>
                <p class="text-indent-2"><span class="level-num" id="(8)(D)">(D)</span> A clinical researcher providing a covered substance to research subjects as part of a research study approved by a hospital-based institutional review board or an institutional review board accredited by the association for the accreditation of human research protections programs.</p>
                <p class="text-indent-1"><span class="level-num" id="(9)">(9)</span> “Drug” means:</p>
                <p class="text-indent-2"><span class="level-num" id="(9)(A)">(A)</span> Any substance recognized as a drug, medicine, or medicinal chemical in the official United States Pharmacopoeia, official National Formulary, official Homeopathic Pharmacopoeia, or official Veterinary Medicine Compendium or other official drug compendium or any supplement to any of them;</p>
                <p class="text-indent-2"><span class="level-num" id="(9)(B)">(B)</span> Any substance intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in man or other animal;</p>
                <p class="text-indent-2"><span class="level-num" id="(9)(C)">(C)</span> Any chemical substance, other than food, intended to affect the structure or any function of the body of man or other animal; and</p>
                <p class="text-indent-2"><span class="level-num" id="(9)(D)">(D)</span> Any substance intended for use as a component of any items specified in subparagraph (A), (B), or (C) of this paragraph, but does not include medical devices or their components, parts, or accessories.</p>
                <p class="text-indent-1"><span class="level-num" id="(10)">(10)</span> “Health occupations board” means a board that, pursuant to § <a class="internal-link" href="/dc/council/code/sections/3-1204.08.html">3-1204.08</a>, licenses and regulates health professionals with the authority to prescribe or dispense covered substances.</p>
                <p class="text-indent-1"><span class="level-num" id="(11)">(11)</span> “Interoperability” means, with respect to a District of Columbia or state prescription drug monitoring program, the ability of that program to share electronically reported prescription information with another state, district, or territory of the United States’ prescription drug monitoring program or a third party, approved by the Director, that operates interstate prescription drug monitoring exchanges.</p>
                <p class="text-indent-1"><span class="level-num" id="(12)">(12)</span> “Patient” means the person or animal who is the ultimate user of a controlled substance or other drug required to be submitted under this chapter for whom a lawful prescription is issued or for whom a controlled substance or such other drug is lawfully dispensed.</p>
                <p class="text-indent-1"><span class="level-num" id="(13)">(13)</span> “Practitioner” shall have the same meaning as provided in § <a class="internal-link" href="/dc/council/code/sections/48-901.02.html">48-901.02</a>(20).</p>
                <p class="text-indent-1"><span class="level-num" id="(14)">(14)</span> “Prescriber” means a practitioner or other authorized person who prescribes a controlled substance or other covered substance in the course of his or her professional practice.</p>
                <p class="text-indent-1"><span class="level-num" id="(15)">(15)</span> “Prescription drug monitoring program” means a program that collects, manages, analyzes, and provides information regarding covered substances or other drugs required to be submitted under this chapter or a program established by a similar act in another state, district, or territory of the United States.</p>
                <p class="text-indent-1"><span class="level-num" id="(16)">(16)</span> “Program” means the Prescription Drug Monitoring Program established by § <a class="internal-link" href="/dc/council/code/sections/48-853.02.html">48-853.02</a>.</p>
                <p class="text-indent-1"><span class="level-num" id="(17)">(17)</span> “Ultimate user” shall have the same meaning as provided in § <a class="internal-link" href="/dc/council/code/sections/48-901.02.html">48-901.02</a>(23).</p>
              </section>
              <br/>
              <section class="line-group annotations">
                <p>
      (<a class="internal-link" href="/dc/council/laws/20-66.html#§2">Feb. 22, 2014, D.C. Law 20-66, § 2, 61 DCR 7</a>.)
    </p>
              </section>
            </section>
            <hr/>
            <h1>§ 48–853.02. Program establishment; Director’s authority.</h1>
            <section>
              <section class="line-group primary-content">
                <p class="text-indent-1"><span class="level-num" id="(a)">(a)</span> There is established the Prescription Drug Monitoring Program within the Department. The Program shall:</p>
                <p class="text-indent-2"><span class="level-num" id="(a)(1)">(1)</span> Establish, maintain, and administer an electronic system to monitor the dispensing of covered substances;</p>
                <p class="text-indent-2"><span class="level-num" id="(a)(2)">(2)</span> Provide dispensers with a basic file layout to enable electronic transmission of the information required under this chapter; and</p>
                <p class="text-indent-2"><span class="level-num" id="(a)(3)">(3)</span> Establish and maintain a process for verifying the credentials of and authorizing the use of prescription information by those individuals and agencies listed in § <a class="internal-link" href="/dc/council/code/sections/48-853.05.html">48-853.05</a>(b) and (c).</p>
                <p class="text-indent-1"><span class="level-num" id="(b)">(b)</span> The Director may contract with another District agency or a private vendor as may be necessary for the implementation and maintenance of the Program. Any such contractor shall be bound to comply with the provisions regarding confidentiality of data in this chapter and shall be subject to the penalties specified in this chapter.</p>
                <p class="text-indent-1"><span class="level-num" id="(c)">(c)</span> The Director shall also establish a multi-discipline advisory committee, which shall function under the Department to assist in the implementation and evaluation of the Program.</p>
              </section>
              <br/>
              <section class="line-group annotations">
                <p>
      (<a class="internal-link" href="/dc/council/laws/20-66.html#§3">Feb. 22, 2014, D.C. Law 20-66, § 3, 61 DCR 7</a>.)
    </p>
                <h4>Section References</h4>
                <p>This section is referenced in § <a class="internal-link" href="/dc/council/code/sections/48-853.01.html">48-853.01</a>.</p>
              </section>
            </section>
            <hr/>
            <h1>§ 48–853.03. Reporting requirements; exceptions.</h1>
            <section>
              <section class="line-group primary-content">
                <p class="text-indent-1"><span class="level-num" id="(a)">(a)</span><span class="level-num" id="(a)(1)">(1)</span> Each dispenser shall submit to the Program the required reporting information for each prescription dispensed for a covered substance within 24 hours after the covered substance is dispensed, unless otherwise established by the Director through rulemaking, but this does not include merely placing the covered substance prescription into a bin for pickup by the ultimate user or his or her agent.</p>
                <p class="text-indent-2"><span class="level-num" id="(a)(2)">(2)</span> Any dispenser located outside the boundaries of the District that is licensed or registered by the District, shall submit the required reporting information to the Program for each prescription dispensed for a covered substance to an ultimate user who resides within the District within 24 hours after the date that the covered substance is dispensed, unless otherwise established by the Director through rulemaking.</p>
                <p class="text-indent-1"><span class="level-num" id="(b)">(b)</span> The failure of any person subject to the reporting requirements of this chapter to report the dispensing of a covered substance, unless otherwise exempted under this chapter, or the willful failure to transmit accurate information shall constitute grounds for:</p>
                <p class="text-indent-2"><span class="level-num" id="(b)(1)">(1)</span> The revocation, suspension, or denial of a District controlled substances registration;</p>
                <p class="text-indent-2"><span class="level-num" id="(b)(2)">(2)</span> Disciplinary action by the relevant health occupations board pursuant to § <a class="internal-link" href="/dc/council/code/sections/3-1205.14.html">3-1205.14</a>(c); and</p>
                <p class="text-indent-2"><span class="level-num" id="(b)(3)">(3)</span> The imposition of civil fines pursuant to § <a class="internal-link" href="/dc/council/code/sections/2-1801.04.html">2-1801.04</a>.</p>
                <p class="text-indent-1"><span class="level-num" id="(c)">(c)</span> Upon dispensing a covered substance, the dispenser of the covered substance shall report the following information to the Program:</p>
                <p class="text-indent-2"><span class="level-num" id="(c)(1)">(1)</span> Patient name;</p>
                <p class="text-indent-2"><span class="level-num" id="(c)(2)">(2)</span> Patient address;</p>
                <p class="text-indent-2"><span class="level-num" id="(c)(3)">(3)</span> Patient date of birth;</p>
                <p class="text-indent-2"><span class="level-num" id="(c)(4)">(4)</span> Patient gender;</p>
                <p class="text-indent-2"><span class="level-num" id="(c)(5)">(5)</span> Dispenser identification number;</p>
                <p class="text-indent-2"><span class="level-num" id="(c)(6)">(6)</span> Prescriber identification number;</p>
                <p class="text-indent-2"><span class="level-num" id="(c)(7)">(7)</span> Date prescription was issued by prescriber;</p>
                <p class="text-indent-2"><span class="level-num" id="(c)(8)">(8)</span> Date prescription was dispensed;</p>
                <p class="text-indent-2"><span class="level-num" id="(c)(9)">(9)</span> Prescription number;</p>
                <p class="text-indent-2"><span class="level-num" id="(c)(10)">(10)</span> Prescription type, whether the prescription is new or is a refill;</p>
                <p class="text-indent-2"><span class="level-num" id="(c)(11)">(11)</span> National Drug Code for the drug dispensed;</p>
                <p class="text-indent-2"><span class="level-num" id="(c)(12)">(12)</span> Quantity dispensed;</p>
                <p class="text-indent-2"><span class="level-num" id="(c)(13)">(13)</span> Number of days’ supply dispensed;</p>
                <p class="text-indent-2"><span class="level-num" id="(c)(14)">(14)</span> Number of refills ordered;</p>
                <p class="text-indent-2"><span class="level-num" id="(c)(15)">(15)</span> Source of payment for the prescription; and</p>
                <p class="text-indent-2"><span class="level-num" id="(c)(16)">(16)</span> Any other required information as specified in the regulations promulgated by the Director to implement this chapter, or as required for the Program to be eligible to receive federal funds.</p>
                <p class="text-indent-1"><span class="level-num" id="(d)">(d)</span> Each dispenser shall transmit the required reporting information in accordance with the manner, format, standards, and schedules established by the Director through rulemaking.</p>
                <p class="text-indent-1"><span class="level-num" id="(e)">(e)</span> The reporting requirements of this chapter shall not apply to the dispensing of covered substances when the dispensing is limited to the following:</p>
                <p class="text-indent-2"><span class="level-num" id="(e)(1)">(1)</span> Administering covered substances;</p>
                <p class="text-indent-2"><span class="level-num" id="(e)(2)">(2)</span> Dispensing covered substances within an appropriately licensed narcotic maintenance program;</p>
                <p class="text-indent-2"><span class="level-num" id="(e)(3)">(3)</span> Dispensing covered substances to inpatients in hospitals or nursing facilities licensed by the Department or facilities that are otherwise authorized by law to operate as hospitals or nursing homes in the District;</p>
                <p class="text-indent-2"><span class="level-num" id="(e)(4)">(4)</span> Dispensing covered substances to inpatients in hospices licensed by the Department; or</p>
                <p class="text-indent-2"><span class="level-num" id="(e)(5)">(5)</span> Dispensing covered substances as otherwise provided in the Department’s regulations.</p>
              </section>
              <br/>
              <section class="line-group annotations">
                <p>
      (<a class="internal-link" href="/dc/council/laws/20-66.html#§4">Feb. 22, 2014, D.C. Law 20-66, § 4, 61 DCR 7</a>.)
    </p>
              </section>
            </section>
            <hr/>
            <h1>§ 48–853.04. Authority to access database.</h1>
            <section>
              <section class="line-group primary-content">
                <p>A prescriber or dispenser authorized to access the information in the possession of the Program pursuant to this chapter may delegate, pursuant to regulations promulgated by the Director to implement the provisions of this section, such authority to up to 2 health care professionals who are:</p>
                <p class="text-indent-1"><span class="level-num" id="(1)">(1)</span> Licensed, registered, or certified by a health occupations board; and</p>
                <p class="text-indent-1"><span class="level-num" id="(2)">(2)</span> Employed at the same facility and under the direct supervision of the prescriber or dispenser.</p>
              </section>
              <br/>
              <section class="line-group annotations">
                <p>
      (<a class="internal-link" href="/dc/council/laws/20-66.html#§5">Feb. 22, 2014, D.C. Law 20-66, § 5, 61 DCR 7</a>.)
    </p>
              </section>
            </section>
            <hr/>
            <h1>§ 48–853.05. Confidentiality of data; disclosure of information; discretionary authority of the Director.</h1>
            <section>
              <section class="line-group primary-content">
                <p class="text-indent-1"><span class="level-num" id="(a)">(a)</span> All data, records, and reports relating to the prescribing and dispensing of covered substances to patients and any abstracts from such data, records, and reports that are in the possession of the Program pursuant to this chapter and any materials relating to the operation or safety of the Program shall be confidential and shall be exempt from disclosure based on requests made pursuant to subchapter II of Chapter 5 of Title 2 [§ <a class="internal-link" href="/dc/council/code/sections/2-531.html">2-531</a> et seq.]. Information obtained pursuant to the Program may only be disclosed as provided in this chapter.</p>
                <p class="text-indent-1"><span class="level-num" id="(b)">(b)</span> Upon receiving a request for information in accordance with the Department’s regulations and in compliance with applicable District and federal laws and regulations, the Director shall disclose information relevant to:</p>
                <p class="text-indent-2"><span class="level-num" id="(b)(1)">(1)</span> A specific investigation of a specific patient or of a specific dispenser or prescriber to an agent designated by the Chief of the Metropolitan Police Department to conduct drug diversion investigations;</p>
                <p class="text-indent-2"><span class="level-num" id="(b)(2)">(2)</span> An investigation or inspection of or allegation of misconduct by a specific person licensed, certified, or registered by or an applicant for licensure, certification, or registration by a health occupations board or the Department;</p>
                <p class="text-indent-2"><span class="level-num" id="(b)(3)">(3)</span> A disciplinary proceeding before a health occupations board or in any subsequent hearing, trial, or appeal of an action or board order to designated employees of the Department;</p>
                <p class="text-indent-2"><span class="level-num" id="(b)(4)">(4)</span> The proceedings of any grand jury or additional grand jury that has been properly impaneled in accordance with § <a class="internal-link" href="/dc/council/code/sections/11-1916.html">11-1916</a>; and</p>
                <p class="text-indent-2"><span class="level-num" id="(b)(5)">(5)</span> A specific investigation of a specific dispenser or specific prescriber to an agent of the United States Drug Enforcement Administration with authority to conduct drug diversion investigations.</p>
                <p class="text-indent-1"><span class="level-num" id="(c)">(c)</span><span class="level-num" id="(c)(1)">(1)</span> In accordance with the Department’s regulations and applicable federal law and regulations, the Director may, at the Director’s discretion, disclose:</p>
                <p class="text-indent-3"><span class="level-num" id="(c)(1)(A)">(A)</span> Information in the possession of the Program concerning a patient who is over the age of 18 years to that patient, or to the parent or legal guardian of a child aged 18 years or under, unless otherwise prohibited by District or federal law;</p>
                <p class="text-indent-3"><span class="level-num" id="(c)(1)(B)">(B)</span> Information on a specific patient to a prescriber for the purpose of establishing the treatment history of the specific patient when the patient is either under care and treatment by the prescriber or the prescriber is initiating treatment of the patient;</p>
                <p class="text-indent-3"><span class="level-num" id="(c)(1)(C)">(C)</span> Information on a specific patient to a dispenser for the purpose of establishing a prescription history to assist the dispenser in determining the validity of a prescription when the patient is seeking a covered substance from the dispenser or the facility in which the dispenser practices;</p>
                <p class="text-indent-3"><span class="level-num" id="(c)(1)(D)">(D)</span> Information relevant to an investigation or regulatory proceeding of a specific dispenser or prescriber to other regulatory authorities concerned with granting, limiting, or denying licenses, certificates, or registrations to practice a health profession when the regulatory authority licenses the dispenser or prescriber, or the dispenser or prescriber is seeking licensure by a regulatory authority;</p>
                <p class="text-indent-3"><span class="level-num" id="(c)(1)(E)">(E)</span> Information relevant to an investigation relating to a specific dispenser or prescriber who is a participating provider in the District Medicaid program, DC Health Care Alliance, or any other public health care program; information relating to an investigation relating to a specific patient who is currently eligible for and receiving, or who has been eligible for and has received medical assistance services; information relevant to the Medicaid Fraud Control Unit of the Office of the Inspector General, or to designated employees of the Department of Health Care Finance, as appropriate;</p>
                <p class="text-indent-3"><span class="level-num" id="(c)(1)(F)">(F)</span> Information relevant to the determination of the cause of death of a specific patient to the designated employees of the Office of the Chief Medical Examiner; and</p>
                <p class="text-indent-3"><span class="level-num" id="(c)(1)(G)">(G)</span> Information for the purpose of bona fide research or education to qualified personnel; provided, that:</p>
                <p class="text-indent-4"><span class="level-num" id="(c)(1)(G)(i)">(i)</span> Data elements that would reasonably identify a specific patient, prescriber, or dispenser shall be deleted or redacted from the information before disclosure; and</p>
                <p class="text-indent-4"><span class="level-num" id="(c)(1)(G)(ii)">(ii)</span> Release of the information shall only be made pursuant to a written agreement between qualified personnel and the Director to ensure compliance with this chapter.</p>
                <p class="text-indent-2"><span class="level-num" id="(c)(2)">(2)</span> For the purposes of a disclosure under paragraph (1)(B) or (C) of this subsection:</p>
                <p class="text-indent-3"><span class="level-num" id="(c)(2)(A)">(A)</span> The request shall be made and the information shall be provided in the manner specified by the Director through rulemaking; and</p>
                <p class="text-indent-3"><span class="level-num" id="(c)(2)(B)">(B)</span> Notice shall be given to patients that the information described in paragraph (1)(B) or (C) of this subsection, as applicable, may be requested by a prescriber or dispenser participating with the Program.</p>
                <p class="text-indent-1"><span class="level-num" id="(d)">(d)</span> Confidential information that has been received, maintained, or developed by a health occupations board or disclosed by the health occupations board pursuant to this chapter shall not be available for discovery or court subpoena or introduced into evidence in any medical malpractice suit or other action for damages arising out of the provision of or failure to provide services; provided, that this section shall not be construed to inhibit any investigation or prosecution conducted pursuant to this chapter.</p>
              </section>
              <br/>
              <section class="line-group annotations">
                <p>
      (<a class="internal-link" href="/dc/council/laws/20-66.html#§6">Feb. 22, 2014, D.C. Law 20-66, § 6, 61 DCR 7</a>.)
    </p>
                <h4>Section References</h4>
                <p>This section is referenced in § <a class="internal-link" href="/dc/council/code/sections/48-853.02.html">48-853.02</a>.</p>
              </section>
            </section>
            <hr/>
            <h1>§ 48–853.06. Interoperability; information exchange with other prescription drug monitoring programs.</h1>
            <section>
              <section class="line-group primary-content">
                <p class="text-indent-1"><span class="level-num" id="(a)">(a)</span> The Director may enter into written agreements with other prescription drug monitoring programs, or a third party, approved by the Director, that operates an interstate prescription drug monitoring exchange, for the purpose of interoperability and the mutual exchange of information among prescription drug monitoring programs, and describing the terms and conditions for the sharing of prescription information under this section.</p>
                <p class="text-indent-1"><span class="level-num" id="(b)">(b)</span> The Director may provide prescription monitoring information pursuant to such agreements, which shall only use the information for the purposes allowed by this chapter.</p>
                <p class="text-indent-1"><span class="level-num" id="(c)">(c)</span> The Director may request and receive prescription drug monitoring information from other states’ prescription drug monitoring programs and may use the information under the provisions of this chapter.</p>
              </section>
              <br/>
              <section class="line-group annotations">
                <p>
      (<a class="internal-link" href="/dc/council/laws/20-66.html#§7">Feb. 22, 2014, D.C. Law 20-66, § 7, 61 DCR 7</a>.)
    </p>
              </section>
            </section>
            <hr/>
            <h1>§ 48–853.07. Criteria for indicators of misuse; Director’s authority to disclose information; intervention.</h1>
            <section>
              <section class="line-group primary-content">
                <p class="text-indent-1"><span class="level-num" id="(a)">(a)</span> The Director may establish through rulemaking:</p>
                <p class="text-indent-2"><span class="level-num" id="(a)(1)">(1)</span> Criteria for indicators of misuse; and</p>
                <p class="text-indent-2"><span class="level-num" id="(a)(2)">(2)</span> A method for analysis of data collected by the Program using the criteria for indicators of misuse.</p>
                <p class="text-indent-1"><span class="level-num" id="(b)">(b)</span> Upon the development of the criteria and data analysis, the Director may, in addition to the discretionary disclosure of information pursuant to this chapter, disclose information using the criteria that indicates potential misuse by recipients of covered substances to their specific prescribers for the purpose of intervention to prevent such misuse.</p>
              </section>
              <br/>
              <section class="line-group annotations">
                <p>
      (<a class="internal-link" href="/dc/council/laws/20-66.html#§8">Feb. 22, 2014, D.C. Law 20-66, § 8, 61 DCR 7</a>.)
    </p>
              </section>
            </section>
            <hr/>
            <h1>§ 48–853.08. Immunity from liability.</h1>
            <section>
              <section class="line-group primary-content">
                <p class="text-indent-1"><span class="level-num" id="(a)">(a)</span> The Director and the employees of the Department shall not be liable for any civil damages resulting from the accuracy or inaccuracy of any information reported, compiled, or maintained by the Program pursuant to this chapter.</p>
                <p class="text-indent-1"><span class="level-num" id="(b)">(b)</span> The Director and the employees of the Department shall not be liable for any civil damages resulting from the disclosure of or failure to disclose any information in compliance with this chapter and the Department’s regulations.</p>
                <p class="text-indent-1"><span class="level-num" id="(c)">(c)</span> In the absence of gross negligence or willful misconduct, prescribers or dispensers complying in good faith with the reporting requirements of this chapter shall not be liable for any civil damages for any act or omission resulting from the submission of such required reports.</p>
              </section>
              <br/>
              <section class="line-group annotations">
                <p>
      (<a class="internal-link" href="/dc/council/laws/20-66.html#§9">Feb. 22, 2014, D.C. Law 20-66, § 9, 61 DCR 7</a>.)
    </p>
              </section>
            </section>
            <hr/>
            <h1>§ 48–853.09. Unlawful disclosure of information and acts; disciplinary action authorized; penalties.</h1>
            <section>
              <section class="line-group primary-content">
                <p class="text-indent-1"><span class="level-num" id="(a)">(a)</span> It shall be unlawful for any person having access to the confidential information in possession of the Program or any data or reports produced by the Program to disclose the confidential information except as provided in this chapter. Any person who discloses this confidential information in violation of the provisions of this chapter shall be guilty of a misdemeanor upon conviction.</p>
                <p class="text-indent-1"><span class="level-num" id="(b)">(b)</span> It shall be unlawful for any person who lawfully receives confidential information from the Program to redisclose or use the confidential information in any way other than the authorized purpose for which the request was made. Any person who discloses confidential information in violation of this chapter shall be guilty of a misdemeanor upon conviction.</p>
                <p class="text-indent-1"><span class="level-num" id="(c)">(c)</span> Nothing in this section shall prohibit a person who prescribes or dispenses a covered substance required to be reported to the program from redisclosing information obtained from the Program to another prescriber or dispenser who has prescribed or dispensed a covered substance to the same patient.</p>
                <p class="text-indent-1"><span class="level-num" id="(d)">(d)</span> Unauthorized use or disclosure of confidential information received from the Program shall also be grounds for disciplinary action by the relevant health occupations board.</p>
              </section>
              <br/>
              <section class="line-group annotations">
                <p>
      (<a class="internal-link" href="/dc/council/laws/20-66.html#§10">Feb. 22, 2014, D.C. Law 20-66, § 10, 61 DCR 7</a>.)
    </p>
              </section>
            </section>
            <hr/>
            <h1>§ 48–853.10. Rules.</h1>
            <section>
              <section class="line-group primary-content">
                <p>The Director, pursuant subchapter I of Chapter 5 of Title 2 [§ <a class="internal-link" href="/dc/council/code/sections/2-501.html">2-501</a> et seq.], shall issue rules to implement the provisions of this chapter, including the establishment of criteria for granting waivers to the reporting requirements set forth in this chapter.</p>
              </section>
              <br/>
              <section class="line-group annotations">
                <p>
      (<a class="internal-link" href="/dc/council/laws/20-66.html#§11">Feb. 22, 2014, D.C. Law 20-66, § 11, 61 DCR 7</a>.)
    </p>
              </section>
            </section>
            <hr/>
          </section>
        </section>
      </div>
    </main>
    <footer>
      <section class="container center">
        <p>The codes and laws on this website are in the public domain.</p>
        <p>
              Please do not scrape. Instead, bulk download the <a href="https://github.com/dccouncil/dc-law-html">HTML</a> or <a href="https://github.com/dccouncil/dc-law-xml">XML</a>.
            </p>
        <p>Powered by the non-profit <a href="http://www.openlawlib.org/">Open Law Library</a>.</p>
      </section>
    </footer>
    <script type="text/javascript" src="/js/main.js"> </script>
  </body>
</html>
